Drawing for Serial No. 86678056

USPTO serial 86678056

Serial No. 86678056

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
VALLILLO, MELISSA C
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with Serial No. 86678056?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

R. Gwen Peterson

R. GWEN PETERSON Kilpatrick Townsend & Stockton Llp2 Embarcadero Ctr Fl 8San Francisco, CA 94111-3833UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Reagents for medical laboratory and non-medical purposes for use in the field of biotechnology, namely, aqueous and other liquid reagents, solid chemical reagents, and non-reagent consumables, namely, solid substrates for nucleic acid arrays and flow cells enclosing such solid substrates, for use in the field of biotechnology, namely, for use in nucleic acid sequencing, including sample preparation for sequencing; non-reagent consumables, namely, solid substrates for nucleic acid arrays and flow cells enclosing such solid substrates, for use in the field of biotechnology, namely, for use in nucleic acid sequencing, including sample preparation for sequencingACTIVE—
009Computer application software for cloud-based electronic databases in the fields of genomics and genomic analysis, namely, downloadable software for use in storing, visualizing, filtering, assessing and analyzing genomes and their variants, for storing, assessing and analyzing genomic research data, for use in genome sequence analysis and assembly, and for base reading of genomes and their variants; electronic databases recorded on computer media featuring data from nucleic acid sequencing and from nucleic acid sequence data analysis, and computer software in the field of biotechnology, namely, software for use in nucleic acid sequencing and for use in analysis of nucleic acid sequence data; sequencing platforms for use in the biotechnology and genomics field, namely, automated systems for use in nucleic acid sequencing and analysis, the components of which comprise hardware and software for performing sample preparation, nucleic acid sequencing, imaging, and sequence data analysis, and replacement hardware and software for such sequencing platforms; computer hardware for use in the field of biotechnology, namely, for use in genomic research, genome sequencing and analysis, and base reading of genomes; computer software for use in the field of biotechnology, namely, for use in genomic research, genome sequencing and analysis, and base reading of genomesACTIVE—
042Biotechnology research and development services for others, namely, genome sequencing, genome mapping, genome and nucleic acid analysis, genome scanning, and data analysis associated with genome sequencing; providing online, non-downloadable cloud-based software applications for use in assembling, storing, visualizing, filtering, assessing and analyzing nucleic acid sequence data; providing online non-downloadable cloud-based software applications that allow members of an online community to provide, exchange and share information, news and commentary in the fields of genomics and genomic analysis; cloud computing featuring software for use in assembling, storing, visualizing, filtering, assessing and analyzing nucleic acid sequence data in the field of genomics; providing online searchable databases and non-searchable databases featuring scientific information in the fields of genomic information, genomic data and genomic sequence analysis; providing online non-downloadable computer software via the cloud for use in storing, visualizing, filtering, assessing and analyzing genomes and their variants, for storing, assessing and analyzing genomic research data, for use in genome sequence analysis and assembly, and for base reading of genomes and their variantsACTIVE—
044Providing online searchable databases and non-searchable databases featuring medical information in the fields of genomic information, genomic data and genomic sequence analysisACTIVE—
045Licensing of computer software in the field of genome research and developmentACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Sep 5, 2017MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 4, 2017ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 2, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 31, 2017EX1GSOU EXTENSION 1 GRANTED—
Jan 31, 2017EXT1SOU EXTENSION 1 FILED—
Jan 31, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 2, 2016NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 7, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 7, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 18, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 5, 2016PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Apr 28, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 28, 2016XAECEXAMINER'S AMENDMENT ENTERED—
Apr 28, 2016GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 28, 2016GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 28, 2016CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 7, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 7, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 1, 2016ALIEASSIGNED TO LIE—
Mar 22, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 7, 2015GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 7, 2015GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 7, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 6, 2015DOCKASSIGNED TO EXAMINER—
Jul 7, 2015MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Jul 6, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 2, 2015NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance